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Methods
To develop the intervention, a survey of community physiotherapists and national guidelines provided the basis for a consensus workshop through which a protocol was developed for the SUPPORT trial physiotherapist-led exercise programme (SUPPORT: SUbacromial impingement syndrome and Pain: a randomised controlled trial Of exeRcise and injection). The protocol included three stages of exercise progression: 1) scapular stability and active exercise with no resistance 2) range of motion exercise with scapular control, isometrics and stretches, and 3) through range resistance exercise. A two day training programme was developed for physiotherapists which included the trial background, current evidence and strategies to improve exercise adherence.
Results
Twenty physiotherapists were trained to deliver the exercise intervention.
In the SUPPORT trial, 128 participants were randomised to physiotherapist-led exercise. Ninety nine (81%) participants had their first physiotherapy session within 2 to 3 weeks and 71 (56%) received 6 to 8 treatment sessions. Frequently-used exercises were: stage 1 scapular setting with glenohumeral joint (GHJ) flexion to 90 degrees, stage 2 GHJ medial rotation stretch, stage 3 scapular setting through lateral rotation, with resistance bands.
Conclusion:
We combined clinical and research expertise with national guidance in order to
Introduction
Shoulder problems affects one in three adults in their lifetime (1, 2) , peaking between 40 to 60 years and accounting for 1% of primary care consultations (3).
The most common presentation is pain and impaired function (4) (5) (6) .
Subacromial impingement syndrome (SIS) was the most frequent clinical diagnosis and accounted for about half of all shoulder problems (3, 7) . This term was in common use at the start of this trial (2008) and suggested that pain was experienced during elevation of the arm. Previously, pain was thought to be caused by a reduction in the space between the coracoacromial arch of the scapula and the humerus, resulting in a mechanical pinching the soft tissues (8) .
Possible theories included bony abnormalities, weakness or instability in the rotator cuff muscles, impaired scapulohumeral rhythm, scapular instability and poor posture (8, 9) . However, more recent suggestions are that genetics, hormonal influences, lifestyle factors, smoking and alcohol consumption, comorbidities, central sensitisation and excessive and maladaptive loading could also have an influence on the development of this type of shoulder pain.
Therefore, rotator cuff related shoulder pain is a more appropriate and current term that encompasses a range of shoulder aetiologies and pathologies including subacromial impingement syndrome (10) .
Treatment aims to reduce pain and increase function. Previous (8) and current (11) UK guidelines recommend exercise and corticosteroid injection in addition to patient education, oral analgesia and ice-packs. Exercise aims to reduce pain and improve function, posture, muscle strength, range of movement, scapular stability and scapulohumeral rhythm (12) . Exercise can be individualised and supervised (e.g. by physiotherapists) or self-guided from a leaflet (13) .
Previously, one systematic review (14) identified that exercise decreases pain and improves function in the short term, although trials lacked detail of exercise type, frequency and duration. More recently a systematic review (15) reported that combined treatments, composed of exercise and other therapies tended to yield better effects than single interventions.
Most randomised controlled trials (RCTs) (16) (17) (18) (19) (20) (21) (22) are small, of poor quality and focus on short-term results. One found that supervised, physiotherapist-led exercise for SIS led to greater improvements in pain and function than radial extracorporeal shockwave treatment over 18 weeks (23) . Another found no differences between exercise alone and exercise plus corticosteroid injection after 12 or 24 weeks (24) . A further trial showed that a three-month course of specifically tailored, progressive, strengthening exercise was more effective in reducing pain and improving shoulder function in patients with persistent SIS than non-specific movement exercises for the neck and shoulder (25) .
Electromyographic studies (26, 27) have shed some light on the recruitment of muscles during shoulder movement. Rather than muscles working in isolation, many muscles are involved to generate movements and provide counter balance, perhaps indicating the need for function based exercise programmes to replicate the dynamic nature of muscle recruitment.
Guidelines recommend a 'core' set of exercises for SIS, but are based largely on expert opinion (8) . Studies in other musculoskeletal conditions support individualised and progressed exercise rather than standardised exercise (28) but, to date, there are few studies specific to shoulder disorders (29) (ii)
Protocol detail
The trial protocol stipulated that physiotherapists:
• saw patients for their first session within 2 to 3 weeks of randomisation
• delivered between 6 to 8 exercise sessions over 12 weeks
• would offer up to two further appointments if patients did not attend their first appointment
• would discharge patients who failed to attend three consecutive appointments
• provide a first appointment of 40 minutes followed by further appointments of 20 minutes duration
• undertook face-to-face consultations (no phone or e-mail consultations)
• provide patients with exercise diaries to facilitate adherence Available literature at the time suggested for older adults the frequency of strengthening exercise should be at least at least twice per week on nonconsecutive days. There was little evidence to guide dosage and therefore consensus expert opinion was used to inform the protocol recommendation.
The number of exercises recommended suggested 8 to 10 exercises, starting with 1 set, moving to 2 to 3, with mild fatigue on completion (33, 34) . CSP guidance suggested starting strengthening in neutral ranges, arms by side and to use towels / bands for light resistance, ensuring scapular stability during exercise. Whilst there were no guideline recommendations about frequency or number of exercises, they recommended building up to 3 sets of 10 repetitions with 10 seconds rest in between, aiming for moderate effort (8) . National experts, with an interest in the concept of muscle stability, were contacted. They were not aware of any evidence that could underpin decisions about the most appropriate exercise dosage.
Emphasis was placed on assessment / re-assessment to ensure individualised prescription of exercise, progression of the exercise in terms of type and dose. Participants were progressed to using resistance bands or self-resistance. Exercises in stage 1 would be performed on an hourly basis, those in 2 and 3
were to be undertaken 3 to 4 times a day. Table 2 .
Description of intervention delivery in the trial
Of the 661 physiotherapy sessions provided in the trial, assessment / reassessment occurred in almost all (96%), supervised exercises were provided in 92% with education and advice being provided in 88%. Exercises were given to participants and reviewed in 79% of the sessions (n=519). Of the 128 patients randomised to the physiotherapist-led exercise intervention, there was evidence for exercise progression on the CRFs for 87.8% (n=108). The number of patients treated by each physiotherapist ranged from 1 to 15.
To facilitate treatment fidelity, two physiotherapists, who were not involved in delivering the intervention, undertook audits of the CRFs and observed physiotherapists treating SUPPORT trial participants twice during the course of the trial.
Discussion
A physiotherapist-led exercise intervention with key features of individualisation, progression and supervision, was designed and delivered for patients with SIS in the SUPPORT trial. The intervention was developed using a combination of national guidelines, available research evidence and clinical consensus. Similar studies have utilised this approach to develop trial interventions (24) and have recognised the need for specific targeted exercise (37) rather than general exercise (25) . The intervention protocol provides details of the exercises and progressions, addressing criticism of previous trials for poor description of exercise protocols (14) . At the time of development of the exercise intervention, there were no published data upon which to guide the specific number of exercises, nor the specific dose of exercise for patients with SIS. However, our protocol reflects recent international consensus on managing shoulder pain which suggests that active exercises should be the primary treatment approach, with physical assessment findings guiding treatment (38) . This consensus also recommends a limited number of exercises are prescribed and are performed with appropriate scapula-humeral stability. Our intervention was in keeping with this view that regular reassessment allows progression from simple to more demanding shoulder exercises, with progressed loading, with minimal pain and good quality shoulder movements (38) .
In the SUPPORT trial, 81% of patients randomised to the physiotherapist-led intervention received their first treatment session within 3 weeks from randomisation which may not reflect current UK physiotherapy waiting times.
Other trials, investigating the effect of exercise on this population, have seen participants within one week of randomisation (24) . Keeping waiting times to a minimum may reduce non-attendance and encourage participation.
Our intervention was in keeping with other trials which have focused on individualised exercise programmes, exercise progression, correction of performance and tailoring of exercises programmes to suit individual needs (36, 37) . However, some variation in exercise prescription is evident. In our trial, we The authors declare no conflicts of interest. Number of treating physiotherapists 20
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